Celcuity Inc. (CELC) vs Tango Therapeutics, Inc. (TNGX)

A side-by-side comparison of Celcuity Inc. and Tango Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CELC vs TNGX

growth of $100 · dividends reinvested · last 6y
CELC +1339.3% (+56.0%/yr)TNGX +125.6% (+14.5%/yr)CELC compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $100202120222023202420252026$1,439$226
CELC TNGX

CELC vs TNGX: by the numbers

  • •TNGX is the larger company ($3.51B vs $3.50B market cap).
  • •Both run net losses; CELC's is the smaller (0.00% vs -229.92% net margin).

Metrics side by side

Valuation

MetricCELCTNGX
P/S ratioN/A65.26
P/B ratioN/A3.43

Profitability

MetricCELCTNGX
Gross margin0.00%98.25%
Operating margin0.00%-178.39%
Net margin0.00%-229.92%
ROEN/A-12.08%
ROIC-28.15%-12.91%

Growth (annualized)

MetricCELCTNGX
Revenue CAGR (5Y)N/A19.14%
Total return CAGR (5Y)34.40%10.60%

Frequently asked

How have CELC and TNGX total returns compared?
Over the past 5 years, CELC delivered 34.40% and TNGX delivered 10.60% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.